Planet 13 Holdings (PLNH) Cash from Financing Activities (2021 - 2025)
Planet 13 Holdings (PLNH) reported Cash from Financing Activities of $1.8 million for Q2 2025, up 150.55% year-over-year from $698465.9 in Q2 2024, and up 3241.74% quarter-over-quarter from $52368.0 in Q1 2025.
Planet 13 Holdings (PLNH) Cash from Financing Activities (2021 - 2025) Analysis & Trends
Planet 13 Holdings (PLNH) has 5 years of Cash from Financing Activities data on file, last reported at $1.8 million in Q2 2025.
- Cash from Financing Activities for Q2 2025 came in at $1.8 million, up 150.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (up 155.85% YoY), and the FY2025 annual result was $1.8 million, down 73.21% from the prior year.
- Cash from Financing Activities climbed to $1.8 million in Q2 2025 per PLNH's latest filing, from $52368.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $61.2 million in Q1 2021 and troughed at -$3.5 million in Q2 2024.
- A 5-year average of $5.3 million and a median of $75174.0 in 2022 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities surged 5929.2% in 2022, then tumbled 1527700.0% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $17320.0 in 2021, then surged by 5929.2% to $1.0 million in 2022, then slumped by 100.0% to -$3.0 in 2023, then plunged by 1527700.0% to -$45834.0 in 2024, then soared by 3918.13% to $1.8 million in 2025.
- Business Quant data shows PLNH's Cash from Financing Activities at $1.8 million in Q2 2025, $52368.0 in Q1 2025, and -$45834.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | -86.10 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -11.62 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | -18.05 Mn |
| 10 | Planet 13 Holdings | - | - | 9.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Mar 31, 2025 | 52,368.00 |
| Mar 31, 2025 | 52,368.00 |
| Dec 31, 2024 | -45,834.00 |
| Dec 31, 2024 | -45,834.00 |
| Sep 30, 2024 | 322,049.00 |
| Sep 30, 2024 | 322,049.00 |
| Jun 30, 2024 | -3.46 Mn |
| Jun 30, 2024 | -3.46 Mn |
| Mar 31, 2024 | 9.91 Mn |
| Mar 31, 2024 | 9.91 Mn |
| Dec 31, 2023 | -3.00 |
| Dec 31, 2023 | -3.00 |
| Jun 30, 2023 | -267,526.00 |
| Jun 30, 2023 | -267,526.00 |
| Dec 31, 2022 | 1.04 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Jun 30, 2022 | 97,980.00 |
| Jun 30, 2022 | 97,980.00 |